Skip to main content
BIIB
NASDAQ Life Sciences

Italy Opens Antitrust Probe into Biogen Over Alleged Dominance in MS Drug Market

Tom Rudovsky · Reported by Reuters
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$193.08
Mkt Cap
$28.506B
52W Low
$121.05
52W High
$205.97
52W Position info
60% above low
Off High info
6.3% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

BIIB sits 60% above its 52-week low of $121.05.

Summary

Italy's antitrust regulator has opened an investigation into Biogen and its Italian subsidiary, alleging abuse of a dominant position in the multiple sclerosis drug market. The probe focuses on claims that Biogen sought to exclude rival Sandoz from offering natalizumab-based drugs. This development introduces significant regulatory risk for Biogen, potentially leading to fines, market restrictions, or reputational damage in a crucial therapeutic area.

At the time of this announcement, BIIB was trading at $193.08 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $28.5B. The 52-week trading range was $121.05 to $205.97. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

BIIB - Latest Insights

BIIB
Nov 09, 2026, 1:02 AM EST
Source: Reuters
Importance Score:
8
Price at Filing: $248.35
Real-time Price: $253.25 info
Change: +$4.90 (+2%) info
Market Cap: $37.435B info
BIIB
Oct 28, 2026, 6:23 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $252.73
Real-time Price: $253.25 info
Change: +$0.520 (+0.21%) info
Market Cap: $37.435B info
BIIB
Oct 28, 2026, 6:07 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $252.73
Real-time Price: $253.25 info
Change: +$0.520 (+0.21%) info
Market Cap: $37.435B info
BIIB
Oct 28, 2026, 6:00 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $252.73
Real-time Price: $253.25 info
Change: +$0.520 (+0.21%) info
Market Cap: $37.435B info
BIIB
Oct 02, 2026, 11:20 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $221.12
Real-time Price: $253.25 info
Change: +$32.13 (+15%) info
Market Cap: $37.435B info